What steps is CMS taking to improve access to high-cost specialty drugs, particularly for underserved populations served by Indian Health Service and tribal hospitals?
What steps is CMS taking to improve access to high-cost specialty drugs, particularly for underserved populations served by Indian Health Service and tribal hospitals?
How should I report the first and additional single-probe stain procedures when distinguishing between manual and computer-assisted methods?
Do you have any tips for reporting modifier 76?
Can code 94070 be reported multiple times, especially when exposure to specific agents are included, such as antigens?
Under what circumstances can code 96376 be reported in conjunction with 96374 or 96375 for IV push administrations?
To provide you with the most actionable compliance and regulatory questions, we are retiring the pharmacy compliance question of the week to focus on answering more commonly asked questions that safeguard accurate coding and save reimbursement. The pharmacy archive will still be available and is accessible here. Compliance Question of the Week will continue to help you overcome compliance challenges, reduce operational waste, and optimize healthcare.
CPT® copyright 2024 American Medical Association (AMA). All rights reserved.
Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
CPT is a registered trademark of the American Medical Association.
Copyright © 2025 ICD10monitor. Powered by MedLearn Media.
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24